541 related articles for article (PubMed ID: 28619065)
1. Open issues in Mucopolysaccharidosis type I-Hurler.
Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
[TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Remmington T
Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
[TBL] [Abstract][Full Text] [Related]
4. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Wraith JE
Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Wraith JE
Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
[TBL] [Abstract][Full Text] [Related]
8. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
[TBL] [Abstract][Full Text] [Related]
9. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy with laronidase (Aldurazyme
Jameson E; Jones S; Remmington T
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009354. PubMed ID: 31211405
[TBL] [Abstract][Full Text] [Related]
11. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
[TBL] [Abstract][Full Text] [Related]
12. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler.
Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P
Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.
Muñoz-Rojas MV; Bay L; Sanchez L; van Kuijck M; Ospina S; Cabello JF; Martins AM
J Inherit Metab Dis; 2011 Oct; 34(5):1029-37. PubMed ID: 21541721
[TBL] [Abstract][Full Text] [Related]
15. [Hurler syndrome: early diagnosis and treatment].
Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.
Grewal SS; Wynn R; Abdenur JE; Burton BK; Gharib M; Haase C; Hayashi RJ; Shenoy S; Sillence D; Tiller GE; Dudek ME; van Royen-Kerkhof A; Wraith JE; Woodard P; Young GA; Wulffraat N; Whitley CB; Peters C
Genet Med; 2005 Feb; 7(2):143-6. PubMed ID: 15714083
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.
Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF
Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104
[TBL] [Abstract][Full Text] [Related]
18. Early disease progression of Hurler syndrome.
Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
D'Aco K; Underhill L; Rangachari L; Arn P; Cox GF; Giugliani R; Okuyama T; Wijburg F; Kaplan P
Eur J Pediatr; 2012 Jun; 171(6):911-9. PubMed ID: 22234477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]